Sign in Welcome! Log into your account your username your password Forgot your password? Get help Privacy Policy Password recovery Recover your password your email A password will be e-mailed to you. Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching Resource March 31, 2022 Share Telegram WhatsApp Facebook Twitter https://www.cureus.com/articles/82162-ivermectin-prophylaxis-used-for-covid-19-a-citywide-prospective-observational-study-of-223128-subjects-using-propensity-score-matchinghttps://www.cureus.com/articles/82162-ivermectin-prophylaxis-used-for-covid-19-a-citywide-prospective-observational-study-of-223128-subjects-using-propensity-score-matching Ludwig Van Search Latest articles Dispelling the Myth of a Pandemic of the Unvaccinated November 30, 2022 Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales November 10, 2022 Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy October 4, 2022 Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine – Part 2 September 28, 2022 Previous articlePreventive Use of Ivermectin Reduced COVID Mortality by 90%, Study FoundNext articleThe Evidence for Unacceptably High False Positive Rates is Overwhelming Related articles Dispelling the Myth of a Pandemic of the Unvaccinated Resource November 30, 2022 Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales Resource November 10, 2022 Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy Legal action October 4, 2022 Leave a reply Cancel replyLog in to leave a comment
